800 patients help unlock clues to spinal cord recovery
NCT ID NCT07210879
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looks at early factors that might predict how well people recover after a traumatic spinal cord injury. Researchers will examine blood pressure management, pain medications, and biological markers from 800 patients. The goal is to find patterns that help doctors personalize treatment and improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
800 people
The number who actually took part.
- Started
-
Jul 2022
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with traumatic spinal cord injury
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
General Inclusion Criteria: Data from patients who sustained traumatic SCI, and who * completed at least one neurological examination in the acute / sub-acute stage of injury (between the day of injury and 40 days post-SCI) and in the chronic stage of injury (the latest neurological assessment between day 70 and day 546 after SCI) * agreed to provide their medical data for research purposes in the European Multicenter Study about Spinal Cord Injury (EMSCI) database specific for Cohort 1: MAP Cohort patients who * were initially admitted to the BG Trauma Center Murnau, or transferred for acute SCI care within two days after trauma * were treated in the intensive care unit (ICU) and underwent hemodynamic monitoring for at least 24 hours specific for Cohort 2: Biomarker Cohort - patients who had at least five blood samples collected within the first year after injury, with the first sample obtained within two weeks post-injury specific for Cohort 3: Opioid Cohort \- patients who were treated in the ICU and received opioid therapy, including detailed information on timing, dosage, and duration of administration Exclusion Criteria: * Patients with non-traumatic spinal cord injury or non-spinal cord injury * Patients who were initially admitted and/or surgically treated in another hospital and transferred to the BG Trauma Center Murnau later than two days post-SCI
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute traumatic spinal cord injury are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BG Trauma Center Murnau
Murnau am Staffelsee, Bavaria, 82418, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.